← Leaderboards
Edward F Patz
Duke University
$1,534,306
Attributed
$1,534,306
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $277.5K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,534,306 · 6
By mechanism
R01$1,204,568 · 1
R21$301,370 · 1
P41$28,368 · 4
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Dwight D Koeberl$10,403,079
- Joel H Collier$16,512,069
- Bruce R. Donald$11,152,282
- Lubica Rauova$2,618,913
- Michael Rod Zalutsky$18,420,913
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMalignant NeoplasmsMalignant Neoplasm Of LungNeoplasm MetastasisStagingOncologyTumorSeriesDiagnosticDiagnosisBasePrimary NeoplasmMolecular ProfilingExcisionEvaluationPrognosticLung NeoplasmsCancer ModelDiagnostic Neoplasm StagingMaldi-Tof Mass SpectrometryData MiningLaboratoriesIonizationCessation Of Life
Grant awards (12)
ROLE OF HUMORAL IMMUNITY IN METASTASIS$5,460
P41 · FY2010 · RR · contact PI
Discovery of Biomarkers for Lung Cancer Metastasis$150,547
R01 · FY2009 · CA · contact PI
IMAGING EGFR WITH MICRO-PET AND I-124$5,460
P41 · FY2009 · RR · contact PI
Discovery of Biomarkers for Lung Cancer Metastasis$258,053
R01 · FY2008 · CA · contact PI
Discovery of Biomarkers for Lung Cancer Metastasis$258,053
R01 · FY2007 · CA · contact PI
Discovery of Biomarkers for Lung Cancer Metastasis$265,760
R01 · FY2006 · CA · contact PI
ROLE OF CYPA AS A MOLECULAR IMAGING OR THERAPEUTIC TARGET$5,126
P41 · FY2006 · RR · contact PI
Discovery of Biomarkers for Lung Cancer Metastasis$272,155
R01 · FY2005 · CA
ROLE OF CYPA AS A MOLECULAR IMAGING OR THERAPEUTIC TARGET$5,331
P41 · FY2005 · RR
ROLE OF CYPA AS A MOLECULAR IMAGING OR THERAPEUTIC TARGET$6,991
P41 · FY2004 · RR
DEVELOPMENT OF NOVEL TUMOR IMAGING AGENTS$151,698
R21 · FY2001 · CA
DEVELOPMENT OF NOVEL TUMOR IMAGING AGENTS$149,672
R21 · FY2000 · CA